Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

30. March 2020 - 0:00 (CEST)

Epigenomics AG decides to increase share capital by way of private placement

Read more

28. February 2020 - 0:00 (CEST)

Centers for Medicare & Medicaid Services open NCD review process for Epi proColon

Read more

07. November 2019 - 0:00 (CEST)

Epigenomics AG successfully completes capital increase

Read more

Press releases

13. August 2020

Epigenomics AG presents operational highlights and reports financial results for first six months of 2020

Read more

10. August 2020

New study published in the Journal of the National Cancer Institute concludes that Epi proColon(R) is the test of choice for the millions of individuals not willing to participate in FIT or colonoscopy screening

Read more

16. June 2020

Epigenomics AG to Participate in Raymond James Human Health Innovations Conference

Read more